Quarterly report [Sections 13 or 15(d)]

Stockholders' Equity and Share-Based Compensation

v3.25.1
Stockholders' Equity and Share-Based Compensation
3 Months Ended
Mar. 29, 2025
Stockholders' Equity and Share-Based Compensation  
Stockholders' Equity and Share-Based Compensation

Note 3 – Stockholders’ Equity and Share-Based Compensation

Options and Restricted Stock Units

The Company had the following common stock option activity during the thirteen weeks ended March 29, 2025:

Granted options to purchase 100 common shares.
Exercise of 0 options to purchase common shares.
Forfeiture of 0 options to purchase common shares.
Expiration of 58 options to purchase common shares.

The following table summarizes the Company’s restricted stock unit ("RSU") and restricted stock award (“RSA”) activity for the thirteen weeks ended March 29, 2025, and details regarding the awards outstanding and exercisable as of March 29, 2025 (in thousands):

Weighted Average

Grant Date

Aggregate

    

Shares

    

    

Fair Value

    

Intrinsic Value

Vested and expected to vest as of December 28, 2024

5,432

 

Awarded

1,494

 

Vested

(1,034)

 

Forfeited

(51)

 

Awards outstanding, March 29, 2025

5,841

 

$

3.63

 

$

5,315

Vested and expected to vest as of March 29, 2025

5,841

 

$

3.63

 

$

5,315

During the thirteen weeks ended March 29, 2025, 1,034 RSUs that vested were time-based.

For the thirteen weeks ended March 29, 2025, we recorded compensation costs related to stock options, RSUs and RSAs of $3,166. For the thirteen weeks ended March 30, 2024, we recorded compensation costs related to stock options and RSUs of $2,824. As of March 29, 2025, there was unrecognized compensation expense related to stock options, RSUs and RSAs of $11,870 that will be expensed through March 2029.